Share |

roche

FB Roundup: Aster DM Healthcare, Manchester United, Wegmans Food Markets

October 11, 2021

Moopen family’s Aster DM Healthcare partners with Roche Diagnostics in Middle East, Glazer family benefits from share sales in Manchester United, Heiresses in top leadership of Wegmans Food Markets.

Moopen family’s Aster DM Healthcare partners with Roche Diagnostics in Middle East

Aster DM Healthcare, the second-generation Indian family business in Dubai, has entered a strategic partnership for the Middle East “to stay ahead of the curve” with the diagnostics wing of the Swiss fourth-generation healthcare multinational Roche.

FB Roundup: Roche, Henkel, Europa-Park

May 15, 2020

UK joins global clamour for Roche coronavirus testing kits, Henkel quarter rocked by changing consumer demands, Mack family saves the summer season with Europa-Park re-opening.

UK joins global clamour for Roche coronavirus testing kits

The Swiss fourth-generation biotech Roche Group is in demand as the United Kingdom follows the European Union and the United States in approving its coronavirus antibody testing kits for mass use.

FB Roundup: Sodexo, Henkel, Roche

April 3, 2020

Sodexo mobilises and board cut salaries, Henkel makes disinfectants and donates millions, coronavirus-testing Roche hailed by UK government.

Sodexo mobilises globally and board cuts pay to support laid-off staff

The family principal and chiefs of Sodexo, the French family-owned food services and facilities management group, will cut their pay and support their staff made redundant because of the coronavirus outbreak with a $32.6 million fund.

Industrial Foundations: The imperfect solution to long-term prosperity?

August 1, 2018

Industrial foundations lock up generations of family wealth. But what they lack in flexibility they compensate in prospects for long-term prosperity. Scott McCulloch reports

Industrial foundations lock up generations of family wealth. But what they lack in flexibility they compensate in prospects for long-term prosperity. Scott McCulloch reports

Foundations have deep roots in privately-held enterprises, especially in northern Europe’s high-tax jurisdictions. The business model is imperfect, but goes a fair way towards preserving multigenerational wealth.

The families direct investing in infrastructure and renewables

September 10, 2015

For decades, wealthy European families have been deploying part of their capital into infrastructure – and often directly into assets.

For decades, wealthy European families have been deploying part of their capital into infrastructure – and often directly into assets.

Family business roundup: Roche sees marginal decline while Cargill and Vista grow

April 12, 2012

Despite tough market conditions, three family businesses from different parts of the world have posted relatively strong quarterly and annual results this week.

European pharmaceutical giant Roche, controlled by the founding family, saw sales for the first quarter of 2012 fall by 1% to CHF11 billion (€9.15 billion) due to the strength of the Swiss franc. However, revenues at constant exchange rate rose by 2%, the Basel-based company said on 12 April.

Family control lessens at Roche

March 25, 2011

Family-controlled pharmaceutical giant Roche said on 25 March that a member of the family shareholding group has dropped out of the pool, causing the family to lose its voting majority.

The Basel, Switzerland-based company said in a statement that family member Maja Oeri, who has 5% voting rights, dropped out of the group – called the voting pool – reducing the family pool’s voting power to 45% from 50%.

Pharmaceutical giant reports rise in profits

February 2, 2011

Swiss pharmaceutical giant Roche announced on 3 February that its full-year net profits rose by 11% year-on-year, despite putting into place a cost saving restructuring program.

In a statement, the family-controlled company said that its profits increased in 2010 to 8.67 billion Swiss francs (€6.71 billion), from 7.78 billion francs the year before. However, its sales for the year reduced by 3%, attributed to the poor performance of its flu drug Tamiflu.

Eastern Europe: Going east for growth

September 1, 2008

As consumers in Eastern Europe becomes ever more affluent, family businesses around the world are looking to the region for growth rather than cheap land and labour, says Reg Crowder

Family businesses are increasingly turning to Eastern Europe for growth opportunities. But it's a completely different story from what the world saw in the years following the collapse of the Soviet Union.

Roche starts due diligence with Ventana

November 15, 2007

Roche, the family-owned pharmaceutical firm, has entered into a confidentiality agreement with Ventana Medical Systems and will commence due diligence

Roche, the family-owned pharmaceutical firm, has entered into a confidentiality agreement with Ventana Medical Systems and will commence due diligence. This is in regard to Roche's proposal back in June to acquire all outstanding shares of Ventana for a price of $75 per share.

Ventana rejected the offer in June as "grossly inadequate" but have now allowed due diligence to commence in order to "allow Roche to recognise the significant additional value inherent in Ventana's business".